Dividends Calendar Earnings Calendar
OCGN

OCGN | Ocugen Inc

Ocugen Inc

Company profile

  • Industry: Biotechnology
  • Sector: Healthcare
  • Headquarters:   Malvern, Pennsylvania, United States

Company profile

Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing transformative therapies to treat rare and underserved eye diseases. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug ? "one to many" and our novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema and diabetic retinopathy.

  • Subsidiaries:   Histogenics Securities Corporation, ProChon Biotech Ltd., Histogenics Limited

    Key Persons / Board of Directors

    • CEO :  Shankar Musunuri (Sep 2019–)
    • CFO :  Shankar Musunuri


    Jump to (Finance sites)

    Their Official Profiles 

    TwitterLinkedIn

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Internet of Money
    Buy on Amazon

    While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.